Please assess the completion status of the following clinical trial:

Trial Title: Helping Stroke Patients With ThermoSuit Cooling

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ischemic cortical stroke with NIHSS \> _5_;~* Treatment must be initiated within 8 hours from known time of symptom onset or, for eligible patients under the current AHA Guidelines, within the extended time window for mechanical thrombectomy of up to 24 hours.~* Patient dimension criteria: Height: 147-190 cm (58 - 75 in) Width: ≤66 cm (26 in) (elbow to elbow).~Exclusion Criteria:~* Sepsis (bacteremia and clinical syndrome within 72 h);~* Known preexisting coagulopathy, (INR \> 1.3, PTT \>1.5 x control), active bleeding of unknown cause, immune compromised state, thrombocytopenia (platelet count \< 160,000/mm), and history of cold agglutinin disease;~* Hemodynamically significant cardiac dysrhythmias (eg. QTc interval \>450 msec, bradycardia (heart rate less than 50), Mobitz Type II second degree AV block (or higher AV block), and severe ventricular dysrhythmias (sustained VT or VF) ) which cause significant hypotension (SBP ≤ 120 mmHg requiring more than two pressor medications);~* Preexistent illness with life expectancy \<6 months;~* Pregnancy;~* Rapidly improving symptoms;~* Melena, or gross hematuria;~* Sickle cell disease;~* Temperature \< 35°C on admission to Emergency Department;~* Recent (\< 1 week) incisions;~* Any intracerebral hemorrhage;~* A history of a brain vascular lesion (e.G. aneurism or arteriovenous malformation);~* A history of brain disease or damage (e.g. neoplasm or dementia);~* Patients receiving IV tPA \> 3 hours from stroke onset;~* Bradycardia (heart rate ≤ 50);~* High degree AV block;~* Ventricular tachycardia;~* Ventricular fibrillation.~* Significant hypotension \< 120 mm Hg, regardless of the underlying cause~Exclusions for Patients to receive IV tPA :~* Suspicion of subarachnoid hemorrhage on pretreatment evaluation, even with normal neuroimaging;~* Systolic blood pressure greater than 185 mm of Hg or diastolic blood pressure \>110 mmHg at the time of t-PA infusion and/or patient requires aggressive treatment to reduce blood pressure to within these limits;~* Seizure at onset of stroke;~* Active internal bleeding;~* Known bleeding diathesis, including but not limited to:~  * Platelet count less than 100,000/mm3~ * Heparin during the preceding 48 hours and elevated aPTT (greater than upper limit of normal for laboratory)~ * Current use of oral anticoagulants (ex: warfarin) and INR \>1.7;~ * Current use of direct thrombin inhibitors or direct factor Xa inhibitors~ * Elevated prothrombin time (PT) greater than 15 seconds.~* Major surgery or other serious trauma during preceding 14 days;~* Intercranial or intraspinal surgery, stroke, serious head trauma during preceding 3 months;~* Recent arterial puncture at a non-compressible site;~* Recent lumbar puncture during preceding 7 days;~* History of intracranial hemorrhage, neoplasm, arteriovenous malformation, or aneurysm;~* Recent Acute Myocardial Infarction~* Abnormal blood glucose (\<50 or \>400 mg/dL)~* Suspected/confirmed endocarditis~Exclusions for Patients Receiving Neurothrombectomy \>~* Patients with known hypersensitivity to nickel-titanium~* Patients with stenosis and/or pre-existing stent proximal to the thrombus site that may preclude safe recovery of the revascularization device~* Patients with angiographic evidence of carotid dissection

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- ThermoSuit Cooling Induction (Type: EXPERIMENTAL): Induction of therapeutic hypothermia (32-34 degrees C) using the LRS ThermoSuit System. Prior to initiating hypothermia, Magnesium Sulfate will be administered intravenously to control shivering and tPA administered intravenously (if indicated). Induction doses of propofol or etomidate will be used to aid in the suppression of patient discomfort. Neurothrombectomy will be performed if indicated.
- Historical Control (Type: NO_INTERVENTION): Historical patients treated for ischemic stroke using conventional medical treatments, but without induced hypothermia.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: feasibility